Company Showcase Oncology

Karus Therapeutics.

Karus is a clinical-stage biopharmaceutical company developing precision medicines for cancer. Two lead products have both completed Phase I. Their R&D  program is focused on a new generation of brain-penetrant small molecules targeting glioblastoma and other indications.

Karus是一家临床阶段生物制药公司,开发用于治疗癌症的精准药物。两款主导产品均已完成一期临床研究,其研发项目集中于新一代针对胶质母细胞瘤等适应症的脑渗透性小分子。

%d bloggers like this: